This method was utilized for preparing partially purified HBcAg-mZP3 for subsequent experiments. == Physique 5. immunogenic edible baits in reducing the fertility of wild mice through inducing antibodies that cross-react to the zona pellucida. Keywords:contraceptive vaccine, zona pellucida 3 peptide, chimeric virus-like particles, herb molecular farming, oral vaccine,Nicotiana benthamiana == 1. Introduction == Rodents cause economic, social, and environmental damage worldwide and can endanger the health of humans, companion animals, and livestock [1,2]. They can be one of the severe threats to food production in many parts of the world, such as Europe [3], Africa [4,5], Australia [6], and Asia [7,8]. It is necessary to manage the population of rodent pests with a species-specific and more humane approach to reduce their large quantity below the Beta-Lapachone damage threshold [9]. Fertility control has become an acceptable method of wildlife population management compared to standard lethal methods such as culling, trapping, and poisoning that can threaten nontarget species and the environment [10,11,12]. Immunocontraception, the prevention of conception Beta-Lapachone through immunological methods, has been considered a potentially useful method, especially in multiparous species such as mice. Immunocontraception based on gamete-specific molecules involved in spermegg interactions is usually more suitable for achieving acceptable and efficient contraception [13,14,15]. The zona pellucida (ZP) is an extracellular glycoprotein matrix that surrounds growing mammalian oocytes and ovulated eggs and is Beta-Lapachone an essential molecule in spermegg conversation and fertilization [13,16,17]. Immunization against mouse ZP proteins has been extensively investigated, and the potential of ZP as a target to limit mouse populations has been exhibited [11,18,19]. Murine ZP is composed of three glycoproteins: ZP1, ZP2, and ZP3. Mouse ZP3, the primary sperm receptor and acrosome reaction inducer, plays a key role in fertilization and has been suggested as an immunocontraceptive antigen [20,21]. The essential role of the ZP3 glycoprotein in fertilization has been substantiated using ZP3-knockout female mice; ZP3-null female mice are completely infertile [22,23]. Recombinant murine ZP3 antigens have been shown to induce effective contraceptive responses in immunized mice [12,19,24]. Nevertheless, contraceptive vaccines should be effective, inexpensive, and readily applicable. An additional crucial requirement, especially for the field Egf application of contraceptive vaccines, is the species-specificity of the vaccine, which cannot be resolved using protein-based antigens [13,17]. The development of peptide contraceptive antigens can improve the security and specificity of vaccines [25], thereby allowing the oral application of vaccines for wildlife populace control. Peptide-based contraceptive vaccines that target species-specific and functional regions of reproductive antigens can increase the target specificity and reduce the risk of side effects [26,27]. Amino acid residues on ZP3, which are poorly conserved between species, have been explained to be involved in sperm binding, and antibodies against these amino acids interfere with sperm binding [28,29,30]. A mouse-specific ZP3 glycopeptide (mZP3), corresponding to amino acid residues 328342 that contain epitopes (B- and T-cell epitopes) associated with antibody-mediated contraception, has been shown to induce contraceptive antibodies in different mouse strains, including wild mice Beta-Lapachone [31,32,33]. Nevertheless, the immunogenicity of small peptide-based vaccines results in reduced efficacy [25,34]. To compensate for this, an immunogenic carrier molecule can be used to improve the immunogenicity of vaccines [35,36]. One method that has confirmed successful in transporting and delivering peptide epitopes is the use of virus-like particles (VLPs), which are noninfectious particles put together from viral structural proteins [37]. In this study, the hepatitis B core antigen (HBcAg) was used to present the contraceptive mZP3 peptide. Several studies have explained the strong immunogenicity of HBcAg VLPs [38,39,40]. HBcAg VLPs are encouraging carriers for enhancing vaccine immunogenicity [41]. The hepatitis B core (HBc) particles consist of 180 or 240 HBcAg monomers.
This method was utilized for preparing partially purified HBcAg-mZP3 for subsequent experiments